• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600329 Share Price Performance

CN¥46.49
14.86 (46.98%)
CN¥46.49
14.86 (46.98%)
Price CN¥46.49

600329 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

3 Risks
3 Rewards

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Key Details

CN¥5.4b

Revenue

CN¥1.9b

Cost of Revenue

CN¥3.5b

Gross Profit

-CN¥70.2m

Other Expenses

CN¥3.6b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
4.65
65.37%
66.68%
0.2%
View Full Analysis

About 600329

Founded
1981
Employees
4619
CEO
n/a
WebsiteView website
www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People’s Republic of China.

Recent 600329 News & Updates

Recent updates

No updates